Microvessel Density: Correlation between Contrast Ultrasonography and Histology of Prostate Cancer
暂无分享,去创建一个
Hessel Wijkstra | Henk G. van der Poel | H. G. van der Poel | J. A. van der Laak | J. J. de la Rosette | F. Debruyne | J. Rosette | H. Wijkstra | Jeroen A. W. M. van der Laak | G. Leenders | J. Sedelaar | J.P. Michiel Sedelaar | Geert J.L.H. van Leenders | Christian A. Hulsbergen-van de Kaa | Jeroen A.W.M. van der Laak | Frans M.J. Debruyne | Jean J.M.C.H. de la Rosette | Hessel Wijkstraa | G. V. van Leenders | C. A. Hulsbergen-van de Kaa | Michiel Sedelaara | Jean J. M. C. H. de la Rosettea | Geert J. L. H. van Leendersb | Christian A. Hulsbergen-van de Kaab | Henk G. van der Poela | Jeroen A. W. M. van der Laakb | Frans M. J. Debruynea | Frans M.J. Debruyne | H. G. V. D. Poel | C. A. H. D. Kaa
[1] M. Brawer,et al. Topography of neovascularity in human prostate carcinoma , 1995, Cancer.
[2] H. Beerlage,et al. Contrast Angiosonography: A Technology to Improve Doppler Ultrasound Examinations of the Prostate , 1999, European Urology.
[3] D. Bostwick,et al. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma. , 1999, Urology.
[4] D J Ruiter,et al. An improved procedure to quantify tumour vascularity using true colour image analysis. Comparison with the manual hot‐spot procedure in a human melanoma xenograft model , 1998, The Journal of pathology.
[5] M. Brawer,et al. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity , 1994, Cancer.
[6] K. Pienta,et al. Tumor-associated angiogenesis in prostate cancer. , 1993, Anticancer research.
[7] T. Harris,et al. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. , 1989, Journal of immunological methods.
[8] J. Kral,et al. An Analysis of Microvessel Density, Androgen Receptor, p53 and HER-2/neu Expression and Gleason Score in Prostate Cancer , 1998, European Urology.
[9] D. Bostwick,et al. Microvessel density in prostate cancer: prognostic and therapeutic utility. , 1998, Seminars in urologic oncology.
[10] M. Kudo. Imaging Diagnosis of Hepatocellular Carcinoma and Premalignant/Borderline Lesions , 1999, Seminars in liver disease.
[11] G. Miller,et al. Rapid microwave‐stimulated fixation of entire prostatectomy specimens , 1997, The Journal of pathology.
[12] Daan Brandenbarg. The National. , 1892 .
[13] M N Bobrow,et al. Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. , 1991, Journal of immunological methods.
[14] R G Aarnink,et al. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. , 1999, Urology.
[15] P. Troncoso,et al. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. , 1994, Urology.
[16] D O Cosgrove,et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. , 1999, Radiology.
[17] O. Brawley. Prostate carcinoma incidence and patient mortality , 1997, Cancer.
[18] P. Wingo,et al. An adjustment to the 1997 estimate for new prostate cancer cases , 1997, Cancer.
[19] E D Crawford,et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. , 1996, Urology.
[20] D. Rosenthal,et al. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U. S. , 1998 .
[21] S. Fox,et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. , 1996, European journal of cancer.
[22] D. Bostwick,et al. Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis. , 1998, Urology.
[23] M. K. Atilla,et al. The role of power Doppler ultrasonography in the diagnosis of prostate cancer: a preliminary study. , 1998, British journal of urology.
[24] P. Stattin,et al. Vascular density is a predictor of cancer‐specific survival in prostatic carcinoma , 1997, The Prostate.
[25] M. Brawer,et al. Quantitative microvessel density: A staging and prognostic marker for human prostatic carcinoma , 1996, Cancer.
[26] A Heerschap,et al. Fast dynamic gadolinium‐enhanced MR imaging of urinary bladder and prostate cancer , 1999, Journal of magnetic resonance imaging : JMRI.
[27] K. Cummings,et al. National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening. , 1998, Urology.
[28] H. Ragde,et al. Transrectal ultrasound microbubble contrast angiography of the prostate , 1997, The Prostate.
[29] J Kurhanewicz,et al. The prostate: MR imaging and spectroscopy. Present and future. , 2000 .
[30] A. Kim,et al. Contrast‐enhanced power Doppler sonography for the differentiation of cystic renal lesions: preliminary study. , 1999, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[31] E. Speel,et al. Rapid Synthesis of Biotin-, Digoxigenin-, Trinitrophenyl-, and Fluorochrome-labeled Tyramides and Their Application for In Situ Hybridization Using CARD Amplification , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.